161 related articles for article (PubMed ID: 18709987)
21. [A study about normal values of urinary type IV collagen concentration--aim at constructing a diagnostic guideline for diabetic nephropathy].
Sakai H; Tomino Y; Makino H; Arakawa M; Kurokawa K; Haneda M; Moriya T; Inomata S; Katayama S; Iwamoto Y
Nihon Jinzo Gakkai Shi; 2002; 44(5):427-31. PubMed ID: 12216474
[No Abstract] [Full Text] [Related]
22. Glycosaminoglycans urinary excretion as a marker of the early stages of diabetic nephropathy and the disease progression.
Popławska-Kita A; Mierzejewska-Iwanowska B; Szelachowska M; Siewko K; Nikołajuk A; Kinalska I; Górska M
Diabetes Metab Res Rev; 2008; 24(4):310-7. PubMed ID: 18273859
[TBL] [Abstract][Full Text] [Related]
23. Morning home blood pressure may be a significant marker of nephropathy in Japanese patients with type 2 diabetes: ADVANCED-J study 1.
Tanaka Y; Daida H; Imai Y; Miyauchi K; Sato Y; Hiwatari M; Kitagawa A; Kishimoto J; Yamazaki T; Kawamori R
Hypertens Res; 2009 Sep; 32(9):770-4. PubMed ID: 19557003
[TBL] [Abstract][Full Text] [Related]
24. Polymorphism of the aldosterone synthase gene is not associated with progression of diabetic nephropathy, but associated with hypertension in type 2 diabetic patients.
Ko GJ; Kang YS; Lee MH; Song HK; Kim HK; Cha DR
Nephrology (Carlton); 2008 Dec; 13(6):492-9. PubMed ID: 18771471
[TBL] [Abstract][Full Text] [Related]
25. [Evaluation of novel test strip to measure albumin and creatinine in urine].
Tsujikawa H; Machii R; Hiratsuka N; Shiba K; Fukuta I; Kosaka H; Sakamoto H; Oohara K; Hatano K; Ida T
Rinsho Byori; 2005 Feb; 53(2):111-7. PubMed ID: 15796043
[TBL] [Abstract][Full Text] [Related]
26. [Laminin and collagen (type IV)].
Yazawa M; Tsuchida A; Imai Y; Kawazu S
Nihon Rinsho; 2002 Aug; 60 Suppl 8():575-80. PubMed ID: 12355811
[No Abstract] [Full Text] [Related]
27. [Pathophysiological analysis of diabetes mellitus and complications from the urine of diabetic patients].
Aoki N
Rinsho Byori; 1992 Jul; 40(7):736-42. PubMed ID: 1507492
[TBL] [Abstract][Full Text] [Related]
28. [Effect of compound Puerarin on the collage IV in streptozotocin-induced diabetic nephropathy rats].
Li QX; Zhong HJ; Gong HR; Zhu FY; Wang LN; Shen DJ; Li G; Wang CY; Qin CS
Zhonghua Yu Fang Yi Xue Za Zhi; 2008 Apr; 42(4):254-9. PubMed ID: 18763636
[TBL] [Abstract][Full Text] [Related]
29. Electrolytes and NA(+)-K(+)-ATPase: potential risk factors for the development of diabetic nephropathy.
Shahid SM; Mahboob T
Pak J Pharm Sci; 2008 Apr; 21(2):172-9. PubMed ID: 18390448
[TBL] [Abstract][Full Text] [Related]
30. Proteomic identification of urinary biomarkers of diabetic nephropathy.
Rao PV; Lu X; Standley M; Pattee P; Neelima G; Girisesh G; Dakshinamurthy KV; Roberts CT; Nagalla SR
Diabetes Care; 2007 Mar; 30(3):629-37. PubMed ID: 17327332
[TBL] [Abstract][Full Text] [Related]
31. Renal affection in patients with diabetes mellitus is not always caused by diabetic nephropathy.
Zukowska-Szczechowska E; Tomaszewski M
Rocz Akad Med Bialymst; 2004; 49():185-9. PubMed ID: 15631340
[TBL] [Abstract][Full Text] [Related]
32. [Diabetic nephropathies].
Makino H
Nihon Jinzo Gakkai Shi; 2007; Suppl 50th Ann():49-66. PubMed ID: 17899828
[No Abstract] [Full Text] [Related]
33. [Diabetic nephropathy--predictive methods].
Ouchi H; Isogai S
Nihon Rinsho; 2002 Oct; 60 Suppl 10():288-93. PubMed ID: 12430243
[No Abstract] [Full Text] [Related]
34. Diabetic nephropathy in humans: pathologic diversity.
Valk EJ; Bruijn JA; Bajema IM
Curr Opin Nephrol Hypertens; 2011 May; 20(3):285-9. PubMed ID: 21422920
[TBL] [Abstract][Full Text] [Related]
35. Significance of urinary type IV collagen in patients with diabetic nephropathy using a highly sensitive one-step sandwich enzyme immunoassay.
Yagame M; Suzuki D; Jinde K; Saotome N; Sato H; Noguchi M; Sakai H; Kuramoto T; Sekizuka K; Iijima T; Suzuki S; Tomino Y
J Clin Lab Anal; 1997; 11(2):110-6. PubMed ID: 9058245
[TBL] [Abstract][Full Text] [Related]
36. Effect of red wine on urinary protein, 8-hydroxydeoxyguanosine, and liver-type fatty acid-binding protein excretion in patients with diabetic nephropathy.
Nakamura T; Fujiwara N; Sugaya T; Ueda Y; Koide H
Metabolism; 2009 Aug; 58(8):1185-90. PubMed ID: 19481229
[TBL] [Abstract][Full Text] [Related]
37. Urinary type IV collagen in nondiabetic kidney disease.
Furumatsu Y; Nagasawa Y; Shoji T; Yamamoto R; Iio K; Matsui I; Takabatake Y; Kaimori JY; Iwatani H; Kaneko T; Tsubakihara Y; Imai E; Isaka Y; Rakugi H
Nephron Clin Pract; 2011; 117(2):c160-6. PubMed ID: 20699621
[TBL] [Abstract][Full Text] [Related]
38. Urinary detection of type IV collagen and its increase in glomerulonephritis.
Makino H; Hayashi Y; Shikata K; Hirata K; Akiyama K; Ogura T; Obata K; Ota Z
Res Commun Mol Pathol Pharmacol; 1995 May; 88(2):215-23. PubMed ID: 7670853
[TBL] [Abstract][Full Text] [Related]
39. [Determinations of microproteinuria in early diabetic nephropathy].
Kawanishi K; Ishida T; Kajikawa T; Tada S
Rinsho Byori; 1995 May; 43(5):454-9. PubMed ID: 7783362
[TBL] [Abstract][Full Text] [Related]
40. Urinary transforming growth factor-beta(1), collagen IV and the effect of insulin in children at diagnosis of diabetes mellitus.
Holmquist P; Torffvit O
Scand J Urol Nephrol; 2009; 43(2):142-7. PubMed ID: 18979373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
